These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23670113)

  • 1. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease: a systematic review and meta-analysis.
    Henderson P; Anderson NH; Wilson DC
    Am J Gastroenterol; 2014 May; 109(5):637-45. PubMed ID: 23670113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease.
    Henderson P; Casey A; Lawrence SJ; Kennedy NA; Kingstone K; Rogers P; Gillett PM; Wilson DC
    Am J Gastroenterol; 2012 Jun; 107(6):941-9. PubMed ID: 22370604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
    Yang Z; Clark N; Park KT
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal calprotectin in suspected paediatric inflammatory bowel disease.
    Degraeuwe PL; Beld MP; Ashorn M; Canani RB; Day AS; Diamanti A; Fagerberg UL; Henderson P; Kolho KL; Van de Vijver E; van Rheenen PF; Wilson DC; Kessels AG
    J Pediatr Gastroenterol Nutr; 2015 Mar; 60(3):339-46. PubMed ID: 25373864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Laboratory Markers in Addition to Symptoms for Diagnosis of Inflammatory Bowel Disease in Children: A Meta-analysis of Individual Patient Data.
    Holtman GA; Lisman-van Leeuwen Y; Day AS; Fagerberg UL; Henderson P; Leach ST; Perminow G; Mack D; van Rheenen PF; van de Vijver E; Wilson DC; Reitsma JB; Berger MY
    JAMA Pediatr; 2017 Oct; 171(10):984-991. PubMed ID: 28806445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of diagnostic performance between two quantitative rapid fecal calprotectin assays in detecting active inflammatory bowel disease.
    Lee JM; Jang JH; Ryu JH; Yoo J; Lee BI; Kim SJ; Oh EJ
    PLoS One; 2021; 16(8):e0255974. PubMed ID: 34383847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive testing in the management of children with suspected inflammatory bowel disease.
    Dilillo D; Zuccotti GV; Galli E; Meneghin F; Dell'Era A; Penagini F; Colella G; Lewindon P; Carmagnola S; Farina E; Ardizzone S; Maconi G
    Scand J Gastroenterol; 2019 May; 54(5):586-591. PubMed ID: 31032665
    [No Abstract]   [Full Text] [Related]  

  • 8. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.
    Sidler MA; Leach ST; Day AS
    Inflamm Bowel Dis; 2008 Mar; 14(3):359-66. PubMed ID: 18050298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of fecal S100A12 as a novel non-invasive diagnostic biomarker for pediatric inflammatory bowel disease: a systematic review and meta-analysis.
    Witarto BS; Visuddho V; Witarto AP; Sampurna MTA; Irzaldy A
    J Pediatr (Rio J); 2023; 99(5):432-442. PubMed ID: 37094752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary care faecal calprotectin testing in children with suspected inflammatory bowel disease: a diagnostic accuracy study.
    Walker GJ; Chanchlani N; Thomas A; Lin S; Moore L; Heerasing NM; Hendy P; Abdelrahim M; Mole S; Perry MH; Mcdonald TJ; Bewshea CM; Hart JW; Russell RK; Ahmad T; Goodhand JR; Kennedy NA
    Arch Dis Child; 2020 Oct; 105(10):957-963. PubMed ID: 32424002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
    Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
    Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study.
    Kwapisz L; Mosli M; Chande N; Yan B; Beaton M; Micsko J; Mennill PW; Barnett W; Bax K; Ponich T; Howard J; Tirolese A; Lannigan R; Gregor J
    Saudi J Gastroenterol; 2015; 21(6):360-6. PubMed ID: 26655130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy.
    von Roon AC; Karamountzos L; Purkayastha S; Reese GE; Darzi AW; Teare JP; Paraskeva P; Tekkis PP
    Am J Gastroenterol; 2007 Apr; 102(4):803-13. PubMed ID: 17324124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin?
    Di Ruscio M; Vernia F; Ciccone A; Frieri G; Latella G
    Inflamm Bowel Dis; 2017 Dec; 24(1):78-92. PubMed ID: 29272479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
    Voiosu T; Benguş A; Dinu R; Voiosu AM; Bălănescu P; Băicuş C; Diculescu M; Voiosu R; Mateescu B
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):273-8. PubMed ID: 25267955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical usefulness of the faecal calprotectin test in suspected paediatric inflammatory bowel disease.
    Akobeng AK
    Acta Paediatr; 2018 Nov; 107(11):2019-2023. PubMed ID: 29706011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases.
    Diamanti A; Colistro F; Basso MS; Papadatou B; Francalanci P; Bracci F; Muraca M; Knafelz D; De Angelis P; Castro M
    Inflamm Bowel Dis; 2008 Sep; 14(9):1229-35. PubMed ID: 18398894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease.
    Walkiewicz D; Werlin SL; Fish D; Scanlon M; Hanaway P; Kugathasan S
    Inflamm Bowel Dis; 2008 May; 14(5):669-73. PubMed ID: 18240279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease: A Systematic Review and Practical Guide.
    Heida A; Park KT; van Rheenen PF
    Inflamm Bowel Dis; 2017 Jun; 23(6):894-902. PubMed ID: 28511198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies.
    Mao R; Xiao YL; Gao X; Chen BL; He Y; Yang L; Hu PJ; Chen MH
    Inflamm Bowel Dis; 2012 Oct; 18(10):1894-9. PubMed ID: 22238138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.